Sudan: Conflict, cancer care, and ripple effects on the region
Sudan: Conflict, cancer care, and ripple effects on the region
Geriatric oncology in resource-limited settings
Potential benefit to response rates from trastuzumab added to perioperative chemotherapy for patients with HER-2+ GC
Hormonal Therapy and Complications
Selinexor, bortezomib and dexamethasone shows PFS benefit for multiple myeloma
ADCLEC.syn1 and CD33-CARS in humanised acute myeloid leukaemia models shows promising efficacy
Ide-cel significantly prolongs PFS for r/r multiple myeloma versus standard regimens
First-line NALIRIFOX shows improvement in OS and PFS in metastatic pancreatic cancer
ASCO 2023: Latest in PARP inhibitors in prostate cancer
CDK4/6 inhibitors added to first line show no greater benefit when compared to their use in second line therapy in HR+, HER2- ABC
Prognostic value of HER2-low status in breast cancer: A systematic review and meta-analysis
PHERGain trial ID's early breast cancer cases that benefit from dual HER2 blockade without chemo